Skip to main content
Premium Trial:

Request an Annual Quote

Phthisis Signs Distribution Deal for India

NEW YORK (GenomeWeb News) – Phthisis Diagnostics announced that it has signed a distribution deal covering India.

The deal with Genetix Biotech, headquartered in New Delhi, is the first distribution deal by Phthisis in Asia. Genetix, which has more than 30 distributors in India and Southeast Asia, will handle Phthisis' entire product line, including those in development, as part of the deal.

Charlottesville, Va.-based Phthisis currently offers the E-Sphere Simple NA kit for extracting nucleic acids from samples and is targeting molecular diagnostics for parasites and fungi, as well as molecular standards for improving laboratory quality control.

Last month, Phthisis said it raised $410,000 in angel funding. In the spring, it announced its first international distribution deal with Bio Products for Latin America.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.